# COQ2

## Overview
The COQ2 gene encodes the enzyme para-hydroxybenzoate-polyprenyl transferase, a crucial component in the biosynthesis of coenzyme Q10 (CoQ10), an essential lipid-soluble molecule involved in mitochondrial electron transport and cellular antioxidant defense. This enzyme, categorized as a polyprenyl transferase, facilitates the attachment of a polyisoprene tail to the benzoquinone ring, a key step in CoQ10 production (Quinzii2006A; Laredj2014The). The COQ2 protein is an integral membrane protein localized to the inner mitochondrial membrane, where it plays a vital role in energy metabolism and protection against oxidative stress (Ashby1992COQ2; FORSGREN2004Isolation). Mutations in the COQ2 gene can lead to CoQ10 deficiency, resulting in a spectrum of mitochondrial disorders, highlighting the gene's clinical significance (Quinzii2006A; AlcázarFabra2018Clinical).

## Structure
The COQ2 gene encodes a protein involved in the biosynthesis of coenzyme Q10, featuring a polypeptide chain of 421 amino acids (FORSGREN2004Isolation). The protein is predicted to have six transmembrane segments, indicating its localization within the mitochondrial membrane (Ashby1992COQ2; FORSGREN2004Isolation). The COQ2 protein contains a UbiA domain, which is common among polyprenyl transferases, and is involved in the binding of polyprenyl diphosphate substrates (Ashby1992COQ2; FORSGREN2004Isolation).

The primary structure of COQ2 includes a sequence that is 60% identical to the polyprenyl diphosphate substrate-binding site in yeast Coq2 protein (FORSGREN2004Isolation). The secondary structure is predicted to consist largely of beta-strands, as indicated by Chou-Fasman analysis (Ashby1992COQ2). The protein's tertiary structure is not detailed in the available sources, and there is no information on its quaternary structure.

Post-translational modifications and splice variant isoforms of COQ2 are not extensively covered in the provided context. However, the protein's activity in CoQ biosynthesis is crucial for mitochondrial function, and mutations in COQ2 can lead to CoQ10 deficiency (Quinzii2006A).

## Function
The COQ2 gene encodes the enzyme para-hydroxybenzoate-polyprenyl transferase, which plays a critical role in the biosynthesis of coenzyme Q10 (CoQ10) in human cells. This enzyme is responsible for the conjugation of the benzoquinone ring with the polyisoprene tail, a key step in the production of CoQ10, an essential component of the mitochondrial electron transport chain (Quinzii2006A; Laredj2014The). CoQ10 functions as an electron carrier, facilitating the transfer of electrons from complexes I and II to complex III, which is crucial for ATP synthesis through oxidative phosphorylation (Quinzii2006A; Mollet2007Prenyldiphosphate).

In addition to its role in energy production, CoQ10 serves as a lipid-soluble antioxidant, protecting cells from oxidative damage by inhibiting lipid peroxidation and regenerating vitamin E (Bentinger2010Coenzyme). The COQ2 enzyme is an integral membrane protein associated with the inner mitochondrial membrane, where it is active in maintaining cellular energy metabolism and antioxidant defenses (Laredj2014The). Mutations in the COQ2 gene can lead to CoQ10 deficiencies, resulting in various mitochondrial disorders, but supplementation with CoQ10 can improve clinical outcomes if diagnosed early (Bentinger2010Coenzyme; Quinzii2006A).

## Clinical Significance
Mutations in the COQ2 gene are associated with a range of clinical conditions, primarily due to its role in coenzyme Q10 (CoQ10) biosynthesis. COQ2 mutations can lead to primary CoQ10 deficiency, a rare mitochondrial disorder characterized by a variety of symptoms, including encephalomyopathy, nephrotic syndrome, and multiple system atrophy (MSA) (Quinzii2006A; Mollet2007Prenyldiphosphate; AlcázarFabra2018Clinical). 

Patients with COQ2 mutations often present with early-onset nephrotic syndrome, which may be accompanied by encephalopathy and seizures (AlcázarFabra2018Clinical). Some COQ2 variants have been linked to adult-onset MSA, a neurodegenerative disorder characterized by parkinsonism, autonomic failure, and cerebellar ataxia, although this association remains under investigation (Mikasa2018COQ2; Ogaki2014Analysis). 

The clinical manifestations of COQ2 mutations are diverse, ranging from isolated steroid-resistant nephrotic syndrome to severe multisystemic disorders with early mortality (Desbats2014Genetic). The genotype-phenotype correlations are not fully understood, but oral CoQ10 supplementation has shown effectiveness in alleviating some neurological and renal symptoms associated with these mutations (Desbats2014Genetic).


## References


[1. (Desbats2014Genetic) Maria Andrea Desbats, Giada Lunardi, Mara Doimo, Eva Trevisson, and Leonardo Salviati. Genetic bases and clinical manifestations of coenzyme q10(coq10) deficiency. Journal of Inherited Metabolic Disease, 38(1):145–156, August 2014. URL: http://dx.doi.org/10.1007/s10545-014-9749-9, doi:10.1007/s10545-014-9749-9. This article has 181 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10545-014-9749-9)

[2. (FORSGREN2004Isolation) Margareta FORSGREN, Anneli ATTERSAND, Staffan LAKE, Jacob GRÜNLER, Ewa SWIEZEWSKA, Gustav DALLNER, and Isabel CLIMENT. Isolation and functional expression of human coq2, a gene encoding a polyprenyl transferase involved in the synthesis of coq. Biochemical Journal, 382(2):519–526, August 2004. URL: http://dx.doi.org/10.1042/bj20040261, doi:10.1042/bj20040261. This article has 102 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20040261)

[3. (Bentinger2010Coenzyme) Magnus Bentinger, Michael Tekle, and Gustav Dallner. Coenzyme q – biosynthesis and functions. Biochemical and Biophysical Research Communications, 396(1):74–79, May 2010. URL: http://dx.doi.org/10.1016/j.bbrc.2010.02.147, doi:10.1016/j.bbrc.2010.02.147. This article has 322 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2010.02.147)

[4. (Ogaki2014Analysis) Kotaro Ogaki, Shinsuke Fujioka, Michael G Heckman, Sruti Rayaprolu, Alexandra I Soto-Ortolaza, Catherine Labbé, Ronald L Walton, Oswaldo Lorenzo-Betancor, Xue Wang, Yan Asmann, Rosa Rademakers, Neill Graff-Radford, Ryan Uitti, William P Cheshire, Zbigniew K Wszolek, Dennis W Dickson, and Owen A Ross. Analysis of coq2gene in multiple system atrophy. Molecular Neurodegeneration, November 2014. URL: http://dx.doi.org/10.1186/1750-1326-9-44, doi:10.1186/1750-1326-9-44. This article has 39 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1750-1326-9-44)

[5. (Ashby1992COQ2) M.N. Ashby, S.Y. Kutsunai, S Ackerman, A Tzagoloff, and P.A. Edwards. Coq2 is a candidate for the structural gene encoding para-hydroxybenzoate:polyprenyltransferase. Journal of Biological Chemistry, 267(6):4128–4136, February 1992. URL: http://dx.doi.org/10.1016/s0021-9258(19)50638-x, doi:10.1016/s0021-9258(19)50638-x. This article has 157 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(19)50638-x)

[6. (Mikasa2018COQ2) Michitaka Mikasa, Kazuaki Kanai, Yuanzhe Li, Hiroyo Yoshino, Kaoru Mogushi, Arisa Hayashida, Aya Ikeda, Sumihiro Kawajiri, Yasuyuki Okuma, Kenichi Kashihara, Tatsuya Sato, Hiroshi Kondo, Manabu Funayama, Kenya Nishioka, and Nobutaka Hattori. Coq2 variants in parkinson’s disease and multiple system atrophy. Journal of Neural Transmission, 125(6):937–944, April 2018. URL: http://dx.doi.org/10.1007/s00702-018-1885-1, doi:10.1007/s00702-018-1885-1. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00702-018-1885-1)

[7. (Mollet2007Prenyldiphosphate) Julie Mollet, Irina Giurgea, Dimitri Schlemmer, Gustav Dallner, Dominique Chretien, Agnès Delahodde, Delphine Bacq, Pascale de Lonlay, Arnold Munnich, and Agnès Rötig. Prenyldiphosphate synthase, subunit 1 (pdss1) and oh-benzoate polyprenyltransferase (coq2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. Journal of Clinical Investigation, 117(3):765–772, March 2007. URL: http://dx.doi.org/10.1172/jci29089, doi:10.1172/jci29089. This article has 214 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci29089)

[8. (Quinzii2006A) Catarina Quinzii, Ali Naini, Leonardo Salviati, Eva Trevisson, Plácido Navas, Salvatore DiMauro, and Michio Hirano. A mutation in para-hydroxybenzoate-polyprenyl transferase (coq2) causes primary coenzyme q10 deficiency. The American Journal of Human Genetics, 78(2):345–349, February 2006. URL: http://dx.doi.org/10.1086/500092, doi:10.1086/500092. This article has 287 citations.](https://doi.org/10.1086/500092)

[9. (Laredj2014The) Leila N. Laredj, Floriana Licitra, and Hélène M. Puccio. The molecular genetics of coenzyme q biosynthesis in health and disease. Biochimie, 100:78–87, May 2014. URL: http://dx.doi.org/10.1016/j.biochi.2013.12.006, doi:10.1016/j.biochi.2013.12.006. This article has 60 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2013.12.006)

[10. (AlcázarFabra2018Clinical) María Alcázar-Fabra, Eva Trevisson, and Gloria Brea-Calvo. Clinical syndromes associated with coenzyme q10 deficiency. Essays in Biochemistry, 62(3):377–398, July 2018. URL: http://dx.doi.org/10.1042/ebc20170107, doi:10.1042/ebc20170107. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/ebc20170107)